ES2049659A1 - Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. - Google Patents
Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena.Info
- Publication number
- ES2049659A1 ES2049659A1 ES9202005A ES9202005A ES2049659A1 ES 2049659 A1 ES2049659 A1 ES 2049659A1 ES 9202005 A ES9202005 A ES 9202005A ES 9202005 A ES9202005 A ES 9202005A ES 2049659 A1 ES2049659 A1 ES 2049659A1
- Authority
- ES
- Spain
- Prior art keywords
- quinazoline
- chloro
- alkyl
- tyrosine kinase
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
UNA COMPOSICION FARMACEUTICA A BASE DE DERIVADOS DE QUINA ZOLINA CON ACTIVIDAD ANTI-CANCERIGENA. COMPRENDE UN DERIVADO DE QUINAZOLINA DE FORMULA I, EN DONDE, POR EJEMPLO, R1 ES HIDROGENO, TRIFLUORMETILO O NITRO, N ES 1 Y R2 ES HALOGENO, TRIFLUORMETILO, NITRO, CIANO, ALQUILO 1-4C, ALCOXI 1-4C, N-ALQUIL(1-4C)AMINO, N,N-DI-[ALQUIL(1-4C)]AMINO, ALQUIL(1-4C)TIO, ALQUIL(1-4C) SULFINILO O ALQUIL(1-4C)SULFONILO; DILUYENTES O VEHICULOS FARMACEUTICAMENTE ACEPTABLES PARA TALES DERIVADOS; LOS NUEVOS DERIVADOS DE QUINAZOLINA Y UN PROCEDIMIENTO PARA SU PREPARACION; EL USO DE LAS PROPIEDADES INHIBIDORAS DE QUINASA TIROSINICA RECEPTORA DE LOS DERIVADOS DE QUINAZOLINA EN EL TRATAMIENTO DEL CANCER.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9202005A ES2049659B1 (es) | 1992-10-08 | 1992-10-08 | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9202005A ES2049659B1 (es) | 1992-10-08 | 1992-10-08 | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2049659A1 true ES2049659A1 (es) | 1994-04-16 |
ES2049659B1 ES2049659B1 (es) | 1994-10-16 |
Family
ID=8278362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9202005A Expired - Lifetime ES2049659B1 (es) | 1992-10-08 | 1992-10-08 | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2049659B1 (es) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5538325A (en) * | 1978-09-11 | 1980-03-17 | Sankyo Co Ltd | 4-anilinoquinazoline derivative and its preparation |
JPS57144266A (en) * | 1981-03-04 | 1982-09-06 | Sankyo Co Ltd | 4-anilinoquinazoline derivative, its preparation, and analgesic and antiphlogistic agent containing said derivative as active component |
GB2160201A (en) * | 1984-06-14 | 1985-12-18 | Wyeth John & Brother Ltd | Quinazoline and cinnoline derivatives |
GB2188319A (en) * | 1986-03-27 | 1987-09-30 | Ici Plc | Anti-tumour quinazolines |
WO1992014716A1 (en) * | 1991-02-20 | 1992-09-03 | Pfizer Inc. | 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
EP0520722A1 (en) * | 1991-06-28 | 1992-12-30 | Zeneca Limited | Therapeutic preparations containing quinazoline derivatives |
-
1992
- 1992-10-08 ES ES9202005A patent/ES2049659B1/es not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5538325A (en) * | 1978-09-11 | 1980-03-17 | Sankyo Co Ltd | 4-anilinoquinazoline derivative and its preparation |
JPS57144266A (en) * | 1981-03-04 | 1982-09-06 | Sankyo Co Ltd | 4-anilinoquinazoline derivative, its preparation, and analgesic and antiphlogistic agent containing said derivative as active component |
GB2160201A (en) * | 1984-06-14 | 1985-12-18 | Wyeth John & Brother Ltd | Quinazoline and cinnoline derivatives |
GB2188319A (en) * | 1986-03-27 | 1987-09-30 | Ici Plc | Anti-tumour quinazolines |
WO1992014716A1 (en) * | 1991-02-20 | 1992-09-03 | Pfizer Inc. | 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
EP0520722A1 (en) * | 1991-06-28 | 1992-12-30 | Zeneca Limited | Therapeutic preparations containing quinazoline derivatives |
Non-Patent Citations (2)
Title |
---|
BASE DE DATOS JAPIO, 1980, Japan Patent Information Organization, Tokyo, Japón & JP-A-55038325 (SANKYO CO LTD) 17.03.1980 * Resumen * * |
BASE DE DATOS JAPIO, 1982, Japan Patent Information Organization, Tokyo, Japón & JP-A-57144266 (SANKYO CO LTD) 06.09.1982 * Resumen * * |
Also Published As
Publication number | Publication date |
---|---|
ES2049659B1 (es) | 1994-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930000490A (ko) | 치료용 제제 | |
CN1984660B (zh) | 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉 | |
Jafari et al. | Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities | |
US8309562B2 (en) | Compounds and therapeutical use thereof | |
KR940014355A (ko) | 퀴나졸린 유도체 | |
ES2320408T3 (es) | Polimorfo estable de clorhidrato de n-(3-etinilfenilamino)-6,7-bis(2-metoxietoxi)-4-quinazolinamina,procedimientos de produccion y usos farmaceuticos del mismo. | |
EP1642581A3 (en) | Treatment of retinal diseases with quinoxaline derivatives | |
HU211311A9 (en) | Quinazoline derivatives | |
MXPA02001448A (es) | Farmacos antiinflamatorios no esteroides e inhibidores de cinasa del receptor del factor de crecimiento epidermico que contiene composicion para el tratamiento o la inhibicion de polipos colonicos y cancer colorrectal. | |
CZ295468B6 (cs) | Polycyklické sloučeniny | |
MY120400A (en) | Isoxazolecarboxamide derivatives | |
KR20070117547A (ko) | 뇌암 치료방법 | |
WO2009013305A1 (en) | Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members | |
ES2049659A1 (es) | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. | |
US20070244114A1 (en) | Compounds and therapeutical use thereof | |
RU2005133206A (ru) | Производные бензо {1,2,5} тиадиазола | |
De Bree et al. | Imatinib mesilate | |
MX9203692A (es) | Preparaciones terapeuticas. | |
AU2012204048A1 (en) | Nitrogen-containing bicyclic hetroaryl compounds for the treatment of RAF protein kinase-mediated diseases |